Georgetown University Medical Center researchers share the secrets behind “conditional reprogramming” 

Computational protocol may one day enable drug developers to craft novel, therapeutic peptides that precisely target specific disease-causing molecules within the body

“The foundation’s latest gift will allow us to continue to explore important scientific breakthroughs that are high-risk, high-reward endeavors, rarely funded through government grants,” Southern Research president says

Introducing such groups to potential drugs could make them more effective

The study of protein function is necessary for understanding the molecular basis of disease

The man-made, small-molecule drug compound goes after a gene’s ability to produce RNA molecules and certain proteins in melanoma tumors

There is no vaccine currently available for salmonella poisoning

"Our paper shows that it’s possible to attenuate RSV without losing any immunogenicity," says senior author

Research to be presented at the ESMO Asia 2016 Congress

Researchers open new avenues for the development of precision therapeutics targeting RNA

While HPLC and mass spec make inroads into nontraditional markets, interest remains in molecular techniques that address the unique needs of  clinicians and drug developers.

The technology is an influenza B vaccine virus “backbone” that would allow producers to grow vaccine viruses at high yield in mammalian cell culture rather than in eggs